tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ROIV Stock Latest News

Moderna price target raised to $18 from $15 at Leerink
The FlyModerna price target raised to $18 from $15 at Leerink
11h ago
MRNA
ROIV
Einhorn’s DME Capital bought PG&E and United Parks in Q3
PremiumThe Fly
Einhorn’s DME Capital bought PG&E and United Parks in Q3
6d ago
KD
BHF
Roivant Sciences price target raised to $23 from $20 at H.C. Wainwright
PremiumThe Fly
Roivant Sciences price target raised to $23 from $20 at H.C. Wainwright
7d ago
ROIV
Roivant Sciences price target raised to $25 from $21 at Guggenheim
PremiumThe Fly
Roivant Sciences price target raised to $25 from $21 at Guggenheim
7d ago
ROIV
Roivant Sciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
Roivant Sciences Reports Q2 2025 Financial Results
11d ago
ROIV
Roivant Sciences price target raised to $26 from $25 at Citi
PremiumThe FlyRoivant Sciences price target raised to $26 from $25 at Citi
11d ago
ROIV
Promising Developments and Strong Financial Position Justify Buy Rating for Roivant Sciences
Premium
Ratings
Promising Developments and Strong Financial Position Justify Buy Rating for Roivant Sciences
11d ago
ROIV
Roivant Sciences reports Q2 EPS (17c), consensus (30c)
Premium
The Fly
Roivant Sciences reports Q2 EPS (17c), consensus (30c)
11d ago
ROIV
Roivant Sciences sees cash runway into profitability
PremiumThe Fly
Roivant Sciences sees cash runway into profitability
11d ago
ROIV
ROIV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ROIV Upcoming Earnings Report: What to Expect?
14d ago
ROIV
Vor Bio appoints Sokolove as Chief Medical Officer
PremiumThe Fly
Vor Bio appoints Sokolove as Chief Medical Officer
18d ago
VOR
ROIV
Roivant Sciences price target raised to $25 from $16 at Citi
PremiumThe Fly
Roivant Sciences price target raised to $25 from $16 at Citi
23d ago
ROIV
Roivant Sciences files automatic mixed securities shelf
PremiumThe FlyRoivant Sciences files automatic mixed securities shelf
2M ago
ROIV
Hold Rating for Roivant Sciences Amid Promising Developments and Competitive Challenges
Premium
Ratings
Hold Rating for Roivant Sciences Amid Promising Developments and Competitive Challenges
2M ago
ROIV
3 Best Stocks to Buy Now, 9/19/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/19/2025, According to Top Analysts
2M ago
IVA
NVDA
Roivant Sciences price target raised to $16.50 from $12 at BofA
PremiumThe Fly
Roivant Sciences price target raised to $16.50 from $12 at BofA
2M ago
ROIV
TD Cowen initiates $23 price target for Roivant Sciences
PremiumThe Fly
TD Cowen initiates $23 price target for Roivant Sciences
2M ago
ROIV
Roivant Sciences price target raised to $20 from $18 at Jefferies
PremiumThe Fly
Roivant Sciences price target raised to $20 from $18 at Jefferies
2M ago
MRNA
ROIV
Roivant Sciences price target raised to $21 from $15 at Guggenheim
PremiumThe Fly
Roivant Sciences price target raised to $21 from $15 at Guggenheim
2M ago
ROIV
Roivant Sciences price target raised to $20 from $16 at JPMorgan
PremiumThe FlyRoivant Sciences price target raised to $20 from $16 at JPMorgan
2M ago
ROIV
Roivant Sciences price target raised to $20 from $18 at H.C. Wainwright
Premium
The Fly
Roivant Sciences price target raised to $20 from $18 at H.C. Wainwright
2M ago
ROIV
Yaron Werber’s Buy Rating Highlights Brepocitinib’s Potential as a Leading Treatment for Dermatomyositis
Premium
Ratings
Yaron Werber’s Buy Rating Highlights Brepocitinib’s Potential as a Leading Treatment for Dermatomyositis
2M ago
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >